Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
The Vagelos College of Physicians and Surgeons is a thriving institution, setting national and global standards for advancing biomedical research, patient care, and medical education.
A study by Columbia researchers found that prenatal exposure to general anesthesia is associated with a 31% increased risk of being diagnosed with a behavioral disorder during childhood.
Just before turning 40, Larry Abbott switched from physics to theoretical neuroscience. Now, a few decades later, his contributions to brain science have been recognized with the 2024 Brain Prize.
